Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2026-01-01 @ 7:24 AM
Study NCT ID:
NCT01225159
Status:
TERMINATED
Last Update Posted:
2015-12-18
First Post:
2010-07-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tight Glycaemic Control During Cardiac Surgery
Sponsor:
Prince of Songkla University
Organization:
Study Overview
Official Title:
Safety and Efficacy of Tight Glycaemic Control During Cardiac Surgery
Status:
TERMINATED
Status Verified Date:
2015-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Hypoglycaemia is significantly higher in TGC
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TGC
Brief Summary:
To determine whether intraoperative tight glycaemic control can reduce postoperative infection, morbidity and mortality
Detailed Description:
Hyperglycaemia develops frequently in patients undergoing cardiac surgery, especially following cardiopulmonary bypass (CPB). Recent evidence suggests that acute hyperglycaemia adversely affects immune function, wound healing and cardiovascular function.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: